MindWalk Holdings adds Kim Remizowski to board as independent director

MindWalk Holdings Corp. (NASDAQ: HYFT) announced on October 1, 2026 the appointment of Kim Remizowski to its Board of Directors as an independent director, effective September 29, 2026¹. The company said Mr. Remizowski will serve on the Audit Committee and the Compensation, Nomination and Governance Committee¹. The Board determined that he qualifies as an independent director under Nasdaq listing rules and as an audit committee financial expert under applicable SEC rules¹. With the addition, the Board comprises four directors, three of whom are independent¹.

According to the filing, Mr. Remizowski most recently served as Director, Private Equity at Vistra, a global corporate services group operating in more than 50 jurisdictions, where he oversaw governance for a portfolio of investment funds and holding structures¹. The release states he brings more than 35 years of experience in institutional banking and fiduciary oversight, including board service at Merrill Lynch Bank and Trust Company (Cayman) Ltd., Managing Director responsibility at DMS Bank & Trust Ltd., and 17 years at Royal Bank of Canada¹. He is described as a Caymanian who has spent the greater part of his career in the Cayman Islands financial services sector and is an Accredited Director of the Chartered Governance Institute of Canada and a Licensed Director with the Cayman Islands Monetary Authority (CIMA)¹.

The company tied the appointment to its business, noting it comes as MindWalk expands contracted, recurring platform deployments with life sciences clients on ReefIQ, the biological data substrate that provides context for life sciences, powered by HYFT® Technology¹.

The Form 6-K's signature block names "IMMUNOPRECISE ANTIBODIES LTD." rather than MindWalk Holdings Corp., an apparent error in the filing itself; the appointment details above are drawn from the body of the same document, which is signed by Jennifer Bath, President and Chief Executive Officer¹.